Stockscreener 앱 받기
8.53
0.93%
-0.08
시장 영업 전:
8.53
Rxsight Inc 주식(RXST)의 최신 뉴스
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline - Finviz
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead - Intellectia AI
RxSight (RXST) to Release Earnings on Wednesday - Defense World
2026-02-17 | RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
RxSight, Inc. (NASDAQ:RXST) Short Interest Update - MarketBeat
Will RxSight Inc. benefit from geopolitical trendsWeekly Earnings Recap & AI Based Trade Execution Alerts - mfd.ru
Understanding the Setup: (RXST) and Scalable Risk - Stock Traders Daily
What hedge fund activity signals for RxSight Inc. stockJuly 2025 Pullbacks & Low Risk Entry Point Guides - mfd.ru
Can RxSight Inc. reach all time highs this yearIPO Watch & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Options Flow: Will RxSight Inc face regulatory challengesJuly 2025 Action & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
RxSight, Inc. (RXST) initiated at market perform as firm seeks sales reacceleration - MSN
Aug Gainers: Will RxSight Inc benefit from AI trendsMarket Risk Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
What’s the RSI of RxSight Inc. stock2025 Market Trends & Weekly Top Gainers Alerts - mfd.ru
RxSight, Inc. to Report Q4 and Full Year 2025 Financial Results on February 25, 2026 - Quiver Quantitative
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - GlobeNewswire
RxSight, Inc. (RXST) Initiated at Market Perform as Firm Seeks Sales Reacceleration - Insider Monkey
New York State Common Retirement Fund Sells 341,274 Shares of RxSight, Inc. $RXST - MarketBeat
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
Head to Head Analysis: RxSight (NASDAQ:RXST) vs. Edap Tms (NASDAQ:EDAP) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - accessnewswire.com
The Technical Signals Behind (RXST) That Institutions Follow - Stock Traders Daily
RxSight announces executive leadership reorganization and new appointments - MSN
Performance Recap: Is RxSight Inc in a long term uptrendJuly 2025 Institutional & Long-Term Safe Return Strategies - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
Brown Capital Management LLC Trims Stock Position in RxSight, Inc. $RXST - MarketBeat
Aug Action: Is RxSight Inc a potential multi baggerShort Setup & Long-Term Safe Investment Plans - baoquankhu1.vn
Aug Big Picture: Will RxSight Inc outperform tech stocksTrade Analysis Report & Low Volatility Stock Recommendations - baoquankhu1.vn
RxSight stock initiated with Market Perform rating by William Blair - Investing.com UK
Needham Lowers Price Target on RxSight to $13 From $14, Keeps Buy Rating - marketscreener.com
William Blair Initiates Coverage on RxSight With Market Perform - marketscreener.com
William Blair Starts RxSight Inc. (RXST) at Market Perform - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Can RxSight Inc. deliver consistent EPS growth2025 Top Gainers & Weekly High Return Forecasts - mfd.ru
RxSight down on CFO transition - MSN
Baillie Gifford & Co. Raises Stock Holdings in RxSight, Inc. $RXST - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
RxSight price target raised to $9 from $8 at JPMorgan - MSN
Precision Trading with Rxsight Inc. (RXST) Risk Zones - Stock Traders Daily
RxSight (NASDAQ:RXST) Trading Down 0.9%Time to Sell? - MarketBeat
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - PR Newswire
Decliners Report: Is RxSight Inc a potential multi bagger2025 Performance Recap & Risk Controlled Daily Trade Plans - baoquankhu1.vn
How Recent Developments Are Shaping The RxSight (RXST) Investment Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - ACCESS Newswire
Expert Outlook: RxSight Through The Eyes Of 5 Analysts - Benzinga
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - accessnewswire.com
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Do Not Use - ocbj.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
Institution Moves: What is RxSight Incs valuation compared to sectorTrade Performance Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
RxSight (RXST) soars 14.1%: Is further upside left in the stock? - MSN
RxSight stock price target raised to $11.50 from $11.00 at Jefferies - Investing.com Canada
RxSight stock price target raised to $11.50 from $11.00 at Jefferies By Investing.com - Investing.com South Africa
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock? - Nasdaq
1.13%
자본화:
|
볼륨(24시간):